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Visceral adipose tissue (VAT) has multiple roles in
orchestrating whole-body energy homeostasis. In
addition, VAT is now considered an immune site
harboring an array of innate and adaptive immune
cells with a direct role in immune surveillance and
host defense. We report that conventional dendritic
cells (cDCs) in VAT acquire a tolerogenic phenotype
through upregulation of pathways involved in adipo-
cyte differentiation. While activation of the Wnt/
b-catenin pathway in cDC1 DCs induces IL-10 pro-
duction, upregulation of the PPARg pathway in
cDC2 DCs directly suppresses their activation.
Combined, they promote an anti-inflammatory milieu
in vivo delaying the onset of obesity-induced chronic
inflammation and insulin resistance. Under long-term
over-nutrition, changes in adipocyte biology curtail
b-catenin and PPARg activation, contributing to
VAT inflammation.
INTRODUCTION
Visceral adipose tissue (VAT) is a highly active metabolic and
endocrine organ that secretes cytokines and bioactive media-
tors such as adiponectin, which influences not only body weight
homeostasis, but also insulin sensitivity, inflammation, and lipid
metabolism. VAT can respond rapidly and dynamically to
alterations in nutrient intake through adipocyte expansion
(hypertrophy) and adipogenesis (hyperplasia) buffering most of
the excess or deficit of energy. In mice, during the early stage
of high-fat diet (HFD) exposure, VAT expands at the expense
of adipocyte hypertrophy and it is not until after 8 weeks that
adipocyte hyperplasia can be observed (Wang et al., 2013b).
The expansion and renewal of adipocytes are tightly regulated588 Cell Metabolism 27, 588–601, March 6, 2018 ª 2018 The Author
This is an open access article under the CC BY license (http://creativeat the transcriptional level. In mature adipocytes, peroxisome
proliferator-activated receptor-g (PPARg) regulates lipid accu-
mulation during hypertrophy (Wang et al., 2013a), while the
Wnt/b-catenin pathway controls adipocyte hyperplasia (Christo-
doulides et al., 2009).
VAT contains immune cells that work in cooperation with adi-
pocytes tomaintain the overall metabolism and physiology of the
organ. Under homeostatic conditions, resident immune cells
such as macrophages and regulatory T cells (Tregs) produce
anti-inflammatory cytokines that limit inflammation and maintain
glucose homeostasis (Cipolletta et al., 2012). In addition,
macrophages are present in high numbers in VAT and fulfill
housekeeping functions by removing excess lipids and dead
adipocytes (Chawla et al., 2011). Under chronic over-nutrition,
VAT expansion creates an environmental milieu that promotes
low-grade inflammation with local production of IL-6, TNFa,
and IL-1, and the influx of pro-inflammatory cells (Schipper
et al., 2012). The immune regulatory network in VAT is disrupted
with a decrease in numbers of Tregs and eosinophils and
increased recruitment of activated T cells, IFNg-producing
natural killer (NK) cells, and inflammatory macrophages (Schip-
per et al., 2012). This meta-inflammation has been implicated
as an important etiological factor in the development of insulin
resistance and vascular complications.
The presence of conventional dendritic cells (cDCs) in VAT has
been suggested in numerous studies, but their role in VAT inflam-
mation and metabolic homeostasis remains elusive. cDCs are
usually defined as CD11chi MHCII+-expressing cells. However,
the surface marker CD11c has been used to identify inflamma-
tory VAT-infiltrated macrophages (Patsouris et al., 2008). This
phenotypic overlap has made it difficult to accurately charac-
terize and study cDCs in VAT. Under prolonged over-nutrition,
MHCII+CD11c+ cells have been shown to process and present
antigens to T cells and to induce Th17 responses. Depletion of
all CD11c+ cells (including CD11c+ monocytes/macrophages)
resulted in a rapid normalization of insulin sensitivity and
decrease of pro-inflammatory cytokines in obese mice (Bertola
et al., 2012; Patsouris et al., 2008; Stefanovic-Racic et al.,(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
2012), suggesting an inflammatory phenotype. Less is known
about their role in homeostatic conditions. Early work suggested
a preferential recruitment of dendritic cells to perinodal adipose
tissue (Mattacks et al., 2004). More recently, elegant work from
Randolph and colleagues demonstrated that cDCs resident in
perinodal adipose tissue continuously sample lymph content,
including soluble antigens traveling from the tissue to the drain-
ing lymph node (dLN) and hence contributing to the immune
surveillance of neighboring tissues (Kuan et al., 2015). However,
the immune phenotype and the underlying molecular mecha-
nisms that control the immune function of VAT-cDCs in resting
conditions have not yet been explored.
Here we report that steady-state cDCs acquire an anti-inflam-
matory phenotype in VAT, which is regulated by similar pathways
that control adipocyte expansion. Activation of the Wnt/b-cate-
nin pathway in cDC1 DC subset induces the production of
IL-10, while expression of PPARg in cDC2 subset suppresses
the onset of local inflammatory responses. Deletion of b-catenin
and PPARg in cDCs increases VAT-cDC maturation and in-
creases T cell recruitment in lean and obese conditions. The
absence of these regulatory pathways accelerates obesity-
induced chronic inflammation and insulin resistance. Interest-
ingly, under persistent over-nutrition, adipocyte hyperplasia
decreases the availability of b-catenin ligands for cDC1, while
expression of PPARg in cDC2 is reduced, suggesting a possible
mechanism for the pro-inflammatory switch of VAT-cDCs in
obesity.
RESULTS
cDC1 and cDC2 DC Subsets Differentially Upregulate
the b-Catenin and PPARg Pathways in VAT
The promiscuous expression of the markers MHCII and CD11c
within phagocytic cell populations in tissues has hampered the
study of cDCs in VAT. To understand the distinct contribution
of dendritic cells in vivo, new reporter mice have recently
been generated that are based on the expression of the highly
cDC-specific Zbtb46 promoter (Zbtb46-GFP and Zbtb46-Cre)
(Loschko et al., 2016). By using the Zbtb46-GFP mice, which
is expressed on cDCs and the MHCII pre-cDCs, we observed
that, unlike in the spleen, approximately 40% of all CD11chi
MHCII+ cells are cDCs (Figures 1A and 1B). The remaining
cells are characterized by high expression of CD16/32 and
CD11b and negative expression of MerTK and CD64 (Figures
S1A and S1B). CD16/32 can be expressed by monocytes
and monocyte-derived DCs (mo-DCs) (Menezes et al., 2016).
However, they are negative for the mo-DC marker CD206 (Fig-
ure S1B), suggesting that they may be monocytes with low
CD64 expression. Further future characterization is required,
which is beyond the scope of this paper. In concordance
with previous reports, Zbtb46-GFP+ cDCs are strategically
located close to blood and lymphatic vessels, consistent
with their proposed role in antigen sampling (Figure S1C)
(Kuan et al., 2015).
cDCs are present in two main subsets, cDC1 (CD103+) and
cDC2 (CD11b+), which have been shown to have both distinct
and overlapping functions (Merad et al., 2013). We asked if
this ‘‘division of labor’’ could also apply to VAT-resident cDCs.
Interestingly, following gene set enrichment analysis (GSEA)pathway analysis we found that the Wnt and PPARg pathways,
which are important for the regulation of adipocyte differentia-
tion and expansion, were selectively upregulated in cDC1 and
cDC2, respectively (Figures 1C and 1D) (Christodoulides
et al., 2009; Farmer, 2006). The protein expression of active
b-catenin was confirmed in Zbtb46-GFP+ sorted VAT-cDC1 by
western blotting, while PPARg protein expression was observed
in Zbtb46-GFP+ VAT-cDC2 (Figure 1E). Interestingly, despite
similar gene expression of Ctnnb1, Fzd1, and Tcf7/2, stabiliza-
tion of b-catenin in splenic cDCs could not be detected (Fig-
ure S1D). This suggests that these cDCs upregulate adipo-
cyte-relevant pathways in order to ‘‘sense’’ changes in tissue
homeostasis.
Wnt/b-catenin signaling in cDCs has been found to limit in-
flammatory responses in the intestine, to induce Tregs, and to
control Th17 responses (Manicassamy et al., 2010; Suryawanshi
et al., 2015). Similarly, PPARg is known to mediate anti-inflam-
matory effects of several immune cell types (Ahmadian et al.,
2013) and to induce CD4 anergy in bone marrow-derived cDCs
(Klotz et al., 2007). To confirm the anti-inflammatory effect of
both pathways, we stimulated Zbtb46-GFP+ sorted VAT-cDC1
and -cDC2with a TLR4 agonist (GLA) in the presence or absence
of the b-catenin pathway activator SB216763 (SB) or the PPARg
agonist Rosiglitazone (RGZ). In line with previous reports, activa-
tion of both pathways suppressed inflammatory responses.
However, in concordance with our GSEA results, SB preferen-
tially reduced IL-6 production in cDC1 subset, while RGZ had
a significant effect on cDC2 (Figure 2A). A reduction of IL-6 pro-
duction in cDC2 could be observed after SB treatment that could
be a result of residual b-catenin expression in those cells or a
non-specific effect of the drug as it did not induce IL-10 produc-
tion. Interestingly, b-catenin activation significantly enhanced
the production of IL-10 from cDC1 from VAT, but not spleen
(Figure 2B).
Previous research has established Wnt/b-catenin signaling as
an important regulator of adipogenesis. Indeed, local production
of the b-catenin agonist WNT10B is known to inhibit pre-adipo-
cyte differentiation (Ross et al., 2000). We confirmed that VAT
cells produce WNT10B by ELISA (Figure 2C). Furthermore, re-
combinant WNT10B was sufficient to induce IL-10 and to sup-
press GLA-induced IL-6 production by VAT-cDC1 at similar
levels to SB (Figures 2D–2F). PPARg can be activated by dietary
lipids, resulting in adipocyte-lipid storage (Wang et al., 2013a).
Therefore, both pathways are constitutively activated during
regular chow-fed diet in adipocytes/pre-adipocytes but also
in tissue-resident cDCs. On this basis, we hypothesized that
activation of the Wnt/b-catenin and PPARg pathway in cDC1
and cDC2, respectively, sustains a tolerogenic phenotype
in VAT-DCs and contributes to the maintenance of tissue
immune-homeostasis.
Zbtb46-Cre-Driven Loss of b-Catenin Results in
Decreased IL-10 Levels in VAT In Vivo
To directly assess the role of these pathways in vivo, we crossed
floxed b-catenin (Ctnnb1fl/fl) or PPARg (Ppargfl/fl) mice with
transgenic Zbtb46-cre (zDC-cre) mice. This abrogates gene
expression specifically in cDCs (Loschko et al., 2016). Unexpect-
edly, b-catenin deletion was lethal due to Zbtb46+ off-target
expression in non-hematopoietic cells. To bypass this issue,Cell Metabolism 27, 588–601, March 6, 2018 589
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Figure 1. VAT-cDC Subsets Differentially Upregulate the Wnt/b-Catenin and PPARg Pathways
(A and B) Spleen (A) and VAT (B) harvested from lean Zbtb46-GFP mice. cDCs identified as CD11chi MHCII+ GFP+ cells by flow cytometry. Dot plots are
representative of five independent experiments (n = 15).
(C) GSEA showing significant enrichment of Wnt/b-catenin signature in CD11chi MHCII+ CD11b cDCs and PPARg signature in CD11chi MHCII+ CD11b+ DCs
from VAT (GEO: GSE37448). Graphs represent enrichment plots; x axis is rank order of genes from the most upregulated to the most downregulated between
cDC2 and cDC1. Bars highlight the position and log2 fold change (L2FC; y axis, left) of genes in the corresponding gene set; red line indicates running enrichment
score (y axis, right). Normalized enrichment score (NES) and p values indicated.
(D) Heatmap of 20 most enriched genes in both pathways.
(E) Expression of active b-catenin and PPARg detected by western blot representative of three independent experiments.
See also Figure S1.we generated chimera mice using bone marrows and fetal liver
cells from conditional cDC-specific Pparg and Ctnnb1 knock-
down, respectively, to keep experimental settings comparable
(chimeric deleted animals are henceforth referred to as
Ctnnb1/ or Pparg /) (Figure S3A). In this model, difference
between groups can only be attributed to cDC as zDC-cre is
exclusively expressed in cDCs. b-catenin and Pparg deletion
was confirmed by western blotting (Figure S3B). First, we deter-
mined if b-catenin and PPARg signaling pathways are critical
for VAT immune homeostasis in steady state. RT-PCR analysis
from lean VAT showed significant decrease of IL-10 levels in
Ctnnb1/ compared to wild-type (WT) mice, which reached
10-fold decrease in the stromal vascular fraction (SVF) where
immune cells are located (Figures 3A and S3C). IL-17 was
significant elevated in the SVF (S3C). This was accompanied590 Cell Metabolism 27, 588–601, March 6, 2018by a significant decrease of Tregs and a slightly increase, albeit
non-significant, of CD4+ T cell recruitment to VAT (Figures 3B,
S2, and S3D). There were no significant differences in IL-10
levels and T cell recruitment between Pparg/ and WT mice
(Figures 3C, 3D, S3E, and S3F). We hypothesized that this could
be the result of two distinct anti-inflammatory mechanisms.
While b-catenin prevents the onset of inflammation through
IL-10 production, PPARg exerts its anti-inflammatory effect by
interfering with transcriptional regulation of ensuing inflamma-
tory responses, including NF-kb signaling (Pascual et al., 2005;
Ricote et al., 1998). Thus, in the absence of inflammation, the
effect of PPARg is not evident.
While immune cells play a key role in the maintenance of a
systemic anti-inflammatory state in lean VAT, it has now become




Figure 2. Activation of the Wnt/b-Catenin and PPARg Pathway in cDC1 and cDC2 DCs, Respectively, Suppresses TLR4-Induced
Inflammation
cDC1 and cDC2 were purified from spleen and VAT by cell sorting as CD11chi MHCII+ GFP+ cells.
(A and B) Cells were incubated overnight with 5 mg GLA in the presence of b-catenin (SB) or PPARg (RGZ) agonist or DMSO control. IL-6 (A) and IL-10 (B)
production in supernatants was measured by ELISA. Bars represent the mean ± SEM and are representative of three independent experiments (n = 9).
(C) A total of 300 mg VAT was isolated from lean mice and cultured overnight (Sup) or immediately lysed (Lys), and Wnt10b production was analyzed by ELISA.
Bars represent the mean ± SEM (n = 3).
(D) Total GFP+ cDCs were purified and cultured overnight with 100 ng/mL recombinant Wnt10b or SB agonist as positive control; IL-10 was determined in the
supernatant by ELISA (n = 9).
(E and F) As described in (D), but in addition, cells were stimulated with GLA in the presence of recombinant Wnt10b; the production of IL-6 (E) and IL-10 (F) was
determined in the supernatant by ELISA. Bars represent themean ± SEMand are representative of three independent experiments (n = 9). Statistical analysis was
performed with Student’s test, *p < 0.05, **p < 0.01, and ***p < 0.0005.Indeed, phagocytic cells in VAT or associated immune clusters
can collect fluids, pathogens, and cells from the peritoneal cavity
and present them to T cells, while cDCs can sample antigens
traveling in the collecting lymphatic (Cruz-Migoni and Caaman˜o,
2016; Kuan et al., 2015). To assess the consequences of
b-catenin and PPARg deletion in VAT-cDC antigen presentation
capacity, we immunized mice intraperitoneally with ovalbumin
(OVA) after OT-II cell transfer. OVA uptake by phagocytic cells
was confirmed by fluorescence microscopy in VAT and flow
cytometry in VAT and dLN (Figures 3E, 3F, and S3G). As ex-
pected due to their high phagocytic capacity, macrophages
have increased OVA uptake (high mean fluorescence). However,
as confirmed by many recent studies (Schreiber et al., 2013),
macrophages have poor antigen presentation function and failed
to induce OT-II proliferation (Figure 3F). OVA uptake could also
be confirmed after subcutaneous (s.c.) and intravenous (i.v.)
immunization (S3H). Consistent with an anti-inflammatory roleof b-catenin signaling in the VAT, only Ctnnb1/ DCs exhibited
significantly increased antigen-specific T cell activation, as evi-
denced by increased OT-II cell division cycles (Figure 3G). This
difference was only observed in VAT, but not in LN or spleen
(data not shown). Although PPARg activation in steady-state
conditions may not significantly affect VAT immune homeosta-
sis, it may be required to suppress inflammatory responses as
observed in vitro (Figure 2A). To test this hypothesis, we immu-
nized mice with OVA in the presence of LPS as adjuvant. As
expected, the number of dividing OT-II cells and the amount of
divisions were increased in Ctnnb1/ mice compared to WT
mice, but this time the same effect was observed in Pparg /
mice in VAT (Figure 3H). Enhanced T cell proliferation was also
observed in mesenteric LN (Figure S3I), consistent with a
previous report describing increased VAT-DC migration to LN
upon inflammation (Kuan et al., 2015). Collectively, these data






Figure 3. Deletion of b-Catenin, but Not Pparg, in cDCs Decreases VAT Anti-inflammatory State in Homeostatic Conditions
(A) qRT-PCR analysis for gene expression in VAT from leanCtnnb1/mice. Expression levels of all genes were normalized against GAPDH RNA. Bars represent
mRNA expression onCtnnb1/ compared toWTmice, which was set as 1 as indicated with dotted line. Error bars indicate the geometric mean of ten biological
replicates.
(B) VAT was digested from lean Ctnnb1/ and WT mice. Total numbers of CD45+ hematopoietic cells, CD4+ T cells, and FoxP3+ Tregs were quantified by flow
cytometry. Bars represent mean ± SEM (n = 6).
(C) As described in (A) but RT-PCR analysis from lean Pparg/ mice.
(D) As described in (B) but graphs represent total cells infiltrated in VAT from lean Pparg/ and WT mice. Immune cells were identified as detailed in Figure S2.
(E) Whole-tissue microscopy depicting in vivo AF555-labeled ovalbumin (OVA, red) uptake by phagocytic cells in VAT after intraperitoneal (i.p.) immunization.
Nuclei labeled by DAPI (blue) and adipocytes by BODIPY (green).
(F) Histograms represent percentage of AF555-OVA uptake of VAT-cDCs (zDC-GFP+ CD11chi MHCII+) and VAT-macrophages (MerTK+CD64+zDC-GFP) after
i.p. injection in vivo. Mice were injected with OVA. Four hours later, VAT-cDCs and VAT-macrophages were isolated, purified by cell sorting, and cultured
with CFSE-labeled OT-II cells in vitro. OT-II division was analyzed by flow cytometry. Histograms show CFSE dilution where sample in gray is cells from
non-immunized mice.
(G) For in vivo antigen presentation, CFSE-labeled OT-II cells were transferred intravenously 1 day before inoculation with 200 mg OVA intraperitoneally. Three
days later, cell division (left) and total number (right) of proliferating OT-II T cells were analyzed in VAT fromCtnnb1/, Pparg/, andWTmice by flow cytometry.
In histogram, samples in gray represent undivided/non-immunized cells. CFSE dilution was analyzed on gated CD45+CD3+CD4+TCRva2+ CFSE+ cells.
(H) As described in (G) but mice were immunized with OVA and 1 mg LPS to induce inflammation and OT-II division was analyzed 2 days after immunization. Bars
represent mean ± SEM of six mice; dot plots are representative of three independent experiments. Statistical analysis was performed with Student’s test,
*p < 0.05, **p < 0.01; n.s., not significant.
See also Figure S3.is required for IL-10 production, recruitment of Tregs, and the
maintenance of an anti-inflammatory state. In addition, IL-10
is known to suppress cDC maturation (Corinti et al., 2001;592 Cell Metabolism 27, 588–601, March 6, 2018De Smedt et al., 1997). In contrast, PPARg stimulation in







Figure 4. Ctnnb1–/– and Pparg–/– Mice Showed No Statistical Significance in Metabolic Parameters on Chow Diet
Ctnnb1/ and Pparg/ mice were fed a chow diet.
(A) Graph shows representative body weights from three independent experiments.
(B) VAT content was calculated as percentage of body weight. Graphs represent the mean ± SEM and are representative of three independent experiments.
(C and D) Fasting insulin (C) and adiponectin (D) were detected by ELISA. Bars represent the mean ± SEM and are representative of three independent
experiments. Statistical analysis was performed with Student’s test.
(E and F)Whole-body glucose homeostasis measured in (E)Ctnnb1/, (F) Pparg/, andWTmice on chow diet by i.p. glucose tolerance tests (GTTs; n = 10) and
insulin tolerance tests (ITTs; n = 10). Statistical significance at different time points analyzed by two-way ANOVAwith Bonferroni’s post-test, *p < 0.05, **p < 0.01,
***p < 0.001, and ****p < 0.0001.VAT inflammation has been associated with adipocyte
dysfunction, increasing the risk of systemic lipid and glucose
metabolic alterations. Despite the signs of reduced VAT anti-in-
flammatory status in lean conditions, this did not translate into
changes in metabolic parameters such as serum insulin and adi-ponectin levels, weight gain (Figures 4A–4D), or increased insulin
resistance as measured by glucose (GTT) and insulin (ITT) toler-
ance tests (Figures 4E and 4F). This was not surprising since
in steady state, VAT inflammation is minimal, local, and easily








Figure 5. Deletion of b-Catenin and Pparg on cDCs Stimulates Pro-inflammatory Responses in VAT upon WD
Mice were fed a WD for 12 weeks to induce VAT low-grade chronic inflammation.
(A) qRT-PCR analysis for the gene expression in VAT and SVF from Ctnnb1/ and WT control mice on WD (12 weeks). Expression levels of all genes were
normalized against GAPDH RNA. Bars represent mRNA expression on Ctnnb1/ compared to WT mice, which was set as 1 as indicated with dotted line. Error
bars indicate the geometric mean of ten biological replicates for VAT and five for SVF.
(B) In vivo antigen presentation was assessed after CFSE-labeled OT-II transfer and immunization with 200 mgOVA intraperitoneally. Three days later, cell division
and total number of proliferating OT-II T cells were analyzed in VAT from Ctnnb1/ and WT mice by flow cytometry. In histogram, samples in gray represent
undivided/non-immunized cells. CFSE dilution was analyzed on gated CD45+CD3+CD4+TCRva2+ CFSE+ cells.
(legend continued on next page)
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cDC-Specific b-Catenin and PPARg Deletions
Exacerbate Obesity-Induced VAT Inflammation and
Insulin Resistance
Our data support a complementary role of cDC1 and cDC2 sub-
sets in the regulation of local VAT homeostasis. A great deal of
evidence suggests that obesity is associated with low-grade
chronic inflammation and that inflammatory responses in VAT
play a causal role in obesity-induced insulin resistance in mice
and humans (Donath et al., 2013). It is, therefore, tempting to
envisage that the anti-inflammatory properties of VAT-DCs
may delay the onset of inflammation during chronic over-nutri-
tion. To ascertain the role of b-catenin and PPARg in cDCs in
the control of obesity-induced VAT inflammation, Ctnnb1/
or Pparg / mice were fed a Western diet (WD) for 12 weeks,
as well as respective control WT mice. A 10-fold decrease in
IL-10 RNA levels in Ctnnb1/mice was accompanied by signif-
icant increase in the T cell chemoattractant CCL17 production
and a switch to IL-17 T cell responses in whole VAT as well
as the SVF (Figure 5A). In addition, the RNA expression of adi-
ponectin, which is expressed by adipocytes, was reduced,
suggesting some degree of adipocyte dysfunction (Figure 5A).
Similar to LPS acute inflammation, in vivo OT-II proliferation
was enhanced in VAT and dLN from Ctnnb1/ compared to
WT mice (Figures 5B and S4A). This effect appears to be medi-
ated by a change in cDC activation status since Ctnnb1/
cDCs isolated from the VAT displayed enhanced activation
and stimulatory capacity in a mixed-leukocyte reaction (MLR),
demonstrating an induction of Th17 T cell responses and reduc-
tion of Tregs (Figures 5D and 5E) compared to WT cDCs. Total
numbers of VAT-infiltrating CD4+ T cells were slightly increased,
albeit not significant, while the numbers of Tregs were signifi-
cantly reduced (Figure 5E). Accordingly, cDC-derived CCL17
has been shown to promote tissue inflammation by restricting
Treg recruitment (Weber et al., 2011). We observed no differ-
ences in immune cell composition in dLNs and spleen with
the exception of increased numbers of migratory cDCs in
dLNs (Figure S4C). Interestingly, Pparg / mice that failed to
show differences during steady-state conditions when fed a
chow diet displayed a significant increase in T cell-mediated
VAT inflammation as evidenced by elevated CCL17 and IL-17
and reduced IL-10 and IFNg RNA levels compared to WT
mice (Figure 5F). Similar to Ctnnb1/, Pparg / cDCs showed
in vivo increased OVA antigen presentation in VAT and dLN
(Figures 5G and S4D) as well as ex vivo enhanced stimulatory
capacity (MLR) with higher induction of IL-17 CD4+ T cell
responses, reduced Treg recruitment (Figures 5H–5J), and
increased migration to dLNs (Figure S4D). In this case, we could
also detect a significant increase in VAT-infiltrated neutrophils,
also evident on chow diet (Figures S4E and S3E), and a
decrease in eosinophils, suggesting a more general pro-inflam-
matory response in the VAT of Pparg / compared to WT mice
(Figure S4E).(C) Ex vivo antigen presentation capacity and activation of VAT-cDCs were evalu
dilution and activation measured by reduced percentages of FoxP3 Treg. Histog
(D) IL-17 production by allogeneic T cells was measured in supernatant.
(E) Total numbers of CD4+ T and Treg cells recruited in VAT. Immune cells were
(F–J) As described in (A)–(G) but VAT inflammation was analyzed in Pparg/ mic
See also Figure S4.Based on these observations, we postulated that the
increased inflammatory T cell response in VAT of mutant mice
could influence whole-body glucose metabolism. b-catenin
and PPARg deletions in cDCs did not affect weight gain, VAT
content, or food intake (Figures 6A, S5A, and S5B). No changes
were observed in leptin levels, but adiponectin was reduced in
Ctnnb1/ compared to WT mice, which confirmed RT-PCR
data (Figures 6B and 6C). Liver weight, adipocyte size, and fat
deposition in the liver remained unchanged (Figures S5C–S5F).
However, cDC-specific Ctnnb1/ and Pparg / mice dis-
played elevated serum insulin levels compared to WT mice (Fig-
ure 6D). In addition, GTTs and ITTs revealed that these mice
were significantly less glucose tolerant andmore insulin resistant
than controls (Figures 6E–6H). In addition, insulin-stimulated
AKT phosphorylation was markedly reduced in deficient mice
compared to controls in VAT and liver (Figures 6I, 6J, S5G, and
S5H). Collectively, these results demonstrate that cDC-specific
deletion of b-catenin and PPARg enhances local inflammatory
responses and aggravates obesity-induced insulin resistance.
VAT Expansion and Inflammation during Long-Term
Over-nutrition Curtail b-Catenin and PPARg Activation
in cDC1 and cDC2, Respectively
During obesity, there is evidence to suggest that cDCs adopt an
activated phenotype contributing to VAT inflammation. Indeed,
chronic over-nutrition promotes cDC recruitment into VAT and
increases cDC activation, resulting in enhanced T cell stimula-
tory capacity and Th17 responses (Figures S6A–S6D). This can
be the consequence of (1) overwhelming inflammation that over-
rides suppressive pathways, (2) inhibition of these pathways in
obesity, or (3) both. Current literature strongly supports the last
hypothesis. WNT10B levels are suppressed in obesity, allowing
adipocyte hyperplasia (Ross et al., 2000). In parallel, upregula-
tion of the protein kinase cyclin-dependent kinase 5 in obesity
promotes PPARg post-transcriptional modifications and inacti-
vation in vivo (Choi et al., 2010; Cipolletta et al., 2015). This phe-
nomenon can be replicated with TNFa treatment in vitro,
providing evidence for an inflammatory origin. Therefore, we
asked if these regulatory pathways remain active under chronic
over-nutrition. Significant reduction of WNT10B could be
confirmed at the transcriptional and protein level (Figures 7A
and 7B). WNT10B expression was only marginally reduced in
Ctnnb1/ andPparg /mice, suggesting that it is largely linked
to adipocyte differentiation rather than inflammation itself (Fig-
ure 7C). As a result, b-catenin activation in vivowas reduced (Fig-
ure 7D). However, total expression of b-catenin was unaltered
(data not shown) and cells were still able to respond to the
b-catenin pathway activator SB ex vivo, albeit at lower levels, re-
flecting the activated state of cDCs in VAT (Figures 7E and 7F).
Simultaneously, we observed reduced expression of PPARg
on VAT-cDC2 from obese mice (Figure 7G). Accordingly, cDC2
from obese VAT treated with RZG in vitro failed to upregulateated by mixed-leukocyte reactions. T cell proliferation was assessed by CFSE
ram and dot plot are representative of three independent experiments.
identified as detailed in Figure S2.
e. Statistical analysis was performed with Student’s test, *p < 0.05, **p < 0.01.






Figure 6. Deletion of b-Catenin and Pparg on cDCs Alters Glucose Homeostasis
(A) Body weight of Ctnnb1/, Pparg/, and WT mice fed WD for 12 weeks.
(B–D) Serum leptin (B), adiponectin (C), and insulin (D) values from fasted mice representative of two independent experiments (n = 10). Statistical analysis was
performed with Student’s test.
(E–H) Systemic glucose homeostasis was measured by ITT (E and G) in Ctnnb1/ (E), Pparg/ (G), and WT control mice fed aWD. Similarly, GTT (F and H) was
assessed in Ctnnb1/ (F) and Pparg/ (H) compared to control mice. Statistical significance at different time points was analyzed by two-way ANOVA with
Bonferroni’s post-test (n = 10).
(I and J) VAT Akt activation followed acute insulin injection. Western blot analysis of VAT extracts showing phosphor-(Ser473) Akt (p-Akt) levels under control and
insulin treatment in Ctnnb1/ (I) and Pparg/ (J) compared to WTmice. Graphs show densitometry of p-Akt/Akt ratios. *p < 0.05, **p < 0.01, and ***p < 0.0005.
See also Figure S5.








Figure 7. Chronic Over-nutrition Reduces Wnt/b-Catenin and Pparg Pathway Activation in VAT-cDCs
Zbtb46-GFP+ mice were fed a chow or WD for 12 weeks.
(A) mRNA expression of Wnt proteins was analyzed by RT-PCR in mice on WD compared to chow diet (12 weeks). Error bars indicate the geometric mean of five
biological replicates.
(B) Wnt10b protein levels were detected in VAT homogenates (n = 3).
(C) mRNA expression of Wnt10b in Ctnnb1/ and Pparg/ mice (n = 10).
(D) Western blot analysis of active b-catenin in purified CD103+ Zbtb46-GFP+ cDCs from chow- and WD-fed mice.
(E and F) cDC purified from spleen and VAT from Zbtb46-GFPmice were incubated overnight with 5 mgGLA in the presence of b-catenin agonist (SB) or DMSO as
control. IL-6 (E) and IL-10 (F) production was measured in supernatants. Bars represent mean ± SD and are representative of two independent experiments
(n = 6).
(G) Western blot analysis of PPARg in purified CD11b+ Zbtb46-GFP+ cDCs from chow- and WD-fed mice.
(H and I) VAT-cDCs were purified from chow- and WD-fed Zbtb46-GFP+ mice. Cells were cultured overnight with PPARg agonist (RGZ), and CD36 expression
was evaluated by flow cytometry (H). Histograms are representative of three independent experiments (H) (n = 3) and mRNA expression of CD36 and other
downstream genes (I) (n = 5).
(legend continued on next page)
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the PPARg-inducible CD36 and the gene expression of other
downstream genes (Figures 7H and 7I), resulting in reduced
anti-inflammatory properties as shown by IL-6 and IL-12 produc-
tion (Figures 7J and 7K). The reduced response to RZG can be
solely due to downregulation of PPARg or to recruitment of
newcomer cells. Several reports describe an inhibition of PPARg
signaling in vivo (Choi et al., 2010). However, decreased expres-
sion of PPARg was recently observed in adipocytes exposed
to free fatty acids (Nguyen et al., 2012). Overall, our findings sug-
gest that chronic over-nutrition partially abrogates the b-catenin
and PPARg anti-inflammatory pathways fueling cDC activation
and VAT T cell-mediated inflammation in vivo.
DISCUSSION
cDC function can be dictated by the tissue microenvironment.
In this work, we have shown that in order to recognize, inte-
grate, and respond to environmental signals, cDCs must first
upregulate pathways relevant for the control of tissue-local ho-
meostasis. In VAT, cDCs are poised to suppress inflammation
by activating the b-catenin and PPARg pathways, which are
important regulatory mechanisms for fat expansion. Interest-
ingly, tissue adaptation was cDC subset specific.
The Wnt/b-catenin pathway is evolutionarily conserved and
plays a prominent role in cell differentiation, growth, proliferation,
survival, and immune cell function (Komiya and Habas, 2008).
b-catenin is continuously synthetized but rapidly degraded in
the proteasome. The binding of Wnt glycoproteins to Frizzled
(Fzd) family receptors in the cell membrane results in the stabili-
zation of b-catenin in the cytoplasm and further translocation into
the nucleus, where activation of T cell factor/lymphoid enhancer
factor (TCF/LEF) and regulation of gene transcription occur.
Several Wnt proteins and Fzd receptors have been described.
In VAT, Wnt signaling regulates adipocyte differentiation.
Expression of WNT10B is highest in pre-adipocytes and rapidly
declines after differentiation. Overexpression of WNT10B stabi-
lizes b-catenin and blocks adipocyte hyperplasia through
TCF7/2 activation in vivo and in vitro (Ross et al., 2000). Similar
to cDCs, pre-adipocytes are also located close to adipose ves-
sels, suggesting a close interaction and crosstalk (Tang et al.,
2008). Interestingly, VAT-cDC1 showed higher expression of
one of the WNT10B receptors, Fzd1, and the transcription factor
Tcf7l2. Activation of b-catenin in cDC1 by WNT10B in the fat in-
duces a tolerogenic phenotype with high production of the anti-
inflammatory cytokine IL-10. Conversely, PPARg is a member of
the nuclear hormone receptor superfamily of transcription fac-
tors. PPARg forms a heterodimer with RXR (retinoic X receptor)
and subsequently regulates the transcription of cognate target
genes involved in lipid and glucose metabolism. PPARg is highly
expressed in VAT, where it is amaster regulator of adipogenesis.
In mature adipocytes, PPARg regulates lipid accumulation and
hypertrophy (Wang et al., 2013a). We found that PPARg expres-
sion was limited to cDC2 and that its activation repressed inflam-(J and K) As described in (E) and (F) but cells were cultured with PPARg agonist ove
mean ± SEM and are representative of two independent experiments. Statist
***p < 0.0005.
See also Figure S6.
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interplay between PPARg and Wnt/b-catenin signaling within
the same cell (Liu et al., 2006). Activation of b-catenin leads to
PPARg repression. Reciprocally, PPARg inhibits the transcrip-
tion of b-catenin (Liu et al., 2006). In this context, this differential
pathway expression between subsets allows cDCs to simulta-
neous recognize and respond to both signals in VAT.
The anti-inflammatory role of the Wnt/b-catenin and the
PPARg pathways has been extensively documented in vitro
and in vivo. Indeed, the pathways can protect mice from DSS-
induced colitis and obesity-induced insulin resistance, and
reduce inflammatory responses during bacterial infections
(Gautier et al., 2012; Silva-Garcı´a et al., 2014). Less is known
about their relevance for the control of tissue homeostasis.
Here we demonstrate that constitutive activation of b-catenin
in VAT-cDC1 promotes an anti-inflammatorymilieu under resting
conditions. Indeed, the absence of b-catenin in cDCs was
sufficient to reduce IL-10 levels and Treg recruitment to VAT
rendering the tissue more susceptible to inflammation. By
contrast, deletion of PPARg in Zbtb46-Cre 3 PPARgflox/flox
mice showed minimal changes in VAT inflammation with some
evidence of increased T cell and neutrophil infiltrates, albeit not
significant. A possible explanation lies in their different mecha-
nism of action. b-catenin activation triggers PI3K/Akt, which in
turns induces IL-10 production (Fu et al., 2015; Manoharan
et al., 2014). In contrast, PPARg can negatively regulate inflam-
matory gene expression through a mechanism termed transre-
pression. This pathway operates by preventing the clearance
of the repressor complex located on the promoter of inflamma-
tory genes such as NF-kb and AP-1 (Glass and Ogawa, 2006).
Thus, PPARg acts as a transcriptional repressor of canonical
NF-kb target genes, which are activated upon TLR stimulation,
but not in resting conditions (Baratin et al., 2015). Indeed, we
observed that IL-6 and T cell stimulatory capacity was elevated
in PPARg/ cDC2 upon TLR4 stimulation.
Chronic VAT inflammation is a common future of obesity and
metabolic syndrome. As individual adipocytes enlarge with
excess of lipids, they undergo molecular and cellular alterations,
resulting in mitochondrial dysfunction, hypoxia, oxidative stress,
and eventually cell death. This creates a first local and then sys-
temic sustained inflammatory response altering whole-body
glucose homeostasis in mice and men (Donath and Shoelson,
2011; Okin and Medzhitov, 2016). In this context, activation of
the Wnt/b-catenin and PPARg pathways in cDC1 and cDC2,
respectively, restrains VAT-T cell recruitment in an attempt to
limit the local inflammatory process. Indeed, micewith cDC-spe-
cific deletion of b-catenin or PPARg show increased VAT inflam-
mation associated with altered T cell responses, as evidenced
by increased CCL17 and IL-17 and decreased IL-10, IFNg, and
Treg recruitment in VAT from obese mice. Elevated IL-17 pro-
duction in knockout mice is most likely a consequence of cDC
activation as shown by CD11c+ MHCII+ isolated from obese
mice. The observed T cell-mediated phenotype, instead of thernight and IL-6 (J) and IL-12 (K) weremeasured in supernatants. Bars represent
ical analysis was performed with Student’s test, *p < 0.05, **p < 0.01, and
innate pro-inflammatory profile in VAT reported upon monocyte/
macrophage manipulation, is likely a consequence of the cDC-
specific models used in this study, confirming the relevance of
cDCs in the control of T cell responses in vivo (Odegaard et al.,
2007). Increased cumulative inflammation in deficient mice
resulted in increased systemic insulin resistance. Changes in
adipocyte size and ectopic lipid deposition in liver were minimal;
however,Ctnnb1/mice exhibited reduced VAT and circulating
adiponectin, which has anti-inflammatory and cardioprotective
functions (den Ruijter et al., 2014). A link between b-catenin
signaling and insulin resistance has been previously described.
Variants of the TCF7/2 gene are linked to increased susceptibility
for type 2 diabetes (Grant et al., 2006), while a SNP in the human
WNT10b gene has been associated with early-onset familial
obesity (Christodoulides et al., 2006). More compellingly,
transgenic mice overexpressing WNT10B in adipocytes resist
HFD-induced adipose tissue accumulation (Wright et al., 2007).
Paradoxically, despite impaired adipogenesis,WNT10B-overex-
pressing mice are more glucose tolerant and insulin sensitive,
effects attributed partially to reduced VAT inflammation (Wright
et al., 2007). Our data suggest an additional mechanism in which
activation of b-catenin by WNT10B in cDC1 can contribute to
insulin sensitivity in FABP4-WNT10B mice. Similarly, PPARg
agonists, often referred to as an ‘‘insulin sensitizer,’’ are potent
oral anti-diabetic drugs. The role of PPARg in VAT immune func-
tion is better known. Macrophage expression of PPARg is
required for their polarization toward an anti-inflammatory
phenotype, and mice deficient in PPARg in their macrophage
population are more prone to whole-body insulin resistance
(Odegaard et al., 2007). In addition, PPARg activation in Tregs
promotes their accumulation in VAT and protection from
obesity-induced insulin resistance (Cipolletta et al., 2012). We
are now proposing a third immune cell type that responds to
PPARg ligands to reduce VAT inflammation.
Long-term over-nutrition induces profound changes in
adipocyte biology that ultimately affect b-catenin and PPARg
signaling. In mice, adipocyte hyperplasia can be observed after
8 weeks of HFD, which translates into reducedWNT10B produc-
tion by pre-adipocytes. In parallel, PPARg signaling is impaired
due to post-transcriptional modifications (Choi et al., 2010;
Cipolletta et al., 2015). Consistent with this observation, we
found that activation of b-catenin in cDC1 was partially reduced
while PPARg expression in cDC2 was decreased. The infiltration
of PPARg low cDC2 cannot be ruled out. In vivo PPARg post-
transcriptional modification in cDC2 from obese mice requires
further investigation. Thus, in the long term, reduction of
b-catenin and PPARg signaling in cDC1 and cDC2, respectively,
may explain the inflammatory phenotype observed in VAT-cDCs
from obese mice and men (Bertola et al., 2012).
The full implications of our findings are yet to be unraveled. In
addition to its metabolic role, VAT is believed to support organ
and immune cell functions. Nearly all internal organs and large
LN in mammals are embedded in firmly attached adipose tissue.
This VAT provides protective ‘‘padding’’ against damage but
also serves for the paracrine release of fatty acids and immune
mediators for proper tissue function (Iacobellis and Bianco,
2011; Pond and Mattacks, 2003). VAT-cDCs are located in close
proximity to lymphatic and blood vessels, where they can sam-
ple blood and lymph content. An elegant in-depth study demon-strated that the inherent permeability of collective lymphatic
vessels allows fat-resident cDCs to sample soluble antigens traf-
ficking from tissue to LNs. Furthermore, cDCs in the fat were also
able to enter the lymphatic vessels and emigrate to adjacent LNs
during inflammation (Kuan et al., 2015). Thus, the tolerogenic
properties of VAT-cDCs may serve as a checkpoint for the
control of tissue inflammation. Under pathological conditions in
which lymphatic permeability is compromised, e.g., sustained
gut inflammation, chronic lymphedema, and obesity, VAT can
be highly infiltrated by antigens leaking out from lymphatic
vessels (Fonseca et al., 2015) or can act as a reservoir for vi-
ruses, bacteria, and parasites (Damouche et al., 2015; Tanowitz
et al., 2017). Therefore, activation of the b-catenin and PPARg
pathways in VAT-cDCs may serve not only to restrain obesity-
induced inflammation, but also to promote pathogen persis-
tence and tumor growth. Future studies to investigate these
possibilities will be of extreme importance.
Limitations of Study
During HFD, thorough studies in mice have identified adipocyte
hyperplasia in VAT, but not in subcutaneous fat. In addition, the
rate of adipocyte hyperplasia is less well understood in human
VAT due to technical difficulties. Thus, caution is advised in
the extrapolation of these results, in particular the decrease of
Wnt10b, to other adipose tissue sites or to human samples.
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Antibodies
Anti-Mouse CD16/32-FITC (clone 93) BioLegend RRID: AB_312805
Anti-Mouse F4/80-PerCP (clone BM8) BioLegend RRID: AB_893484
Anti-Mouse CD206-BV421 (clone C068C2) BioLegend RRID: AB_2562232
Anti-Mouse CD11c-BV605 (clone HL3) BD Biosciences Cat#563057
Anti-Mouse CD11c-BV605 (clone N418) BioLegend RRID: AB_2562415
Anti-Mouse CD103-APC (clone2E7) eBioscience RRID: AB_1106992
Anti-Mouse MHCII-AF700 (clone M5/114.15.2) BioLegend RRID: AB_493727
Anti-Mouse CD11b-AF780 (clone M1/70) eBioscience RRID: AB_1603193
Anti-Mouse MertK-PE R&D Systems Cat#FAB5912P
Anti-Mouse CD45-PE-CF594 (clone 30-F11) BioLegend RRID: AB_2564003
Anti-Mouse CD45-PE-CF594 (clone 30-F11) BD Biosciences RRID: AB_11154401
Anti-Mouse CD64-PE-Cy7 (clone X54-5/7.1) BioLegend RRID: AB_2563904
Anti-Mouse CD8-FITC (clone 53-6.7) eBioscience RRID: AB_464916
Anti-Mouse Ly6G-BV421 (clone IA8) BioLegend RRID: AB_2562567
Anti-Mouse NK1.1-BV605 (clone PK136) BioLegend RRID: AB_2562274
Anti-Mouse CD3-AF700 (clone 17A2) eBioscience RRID: AB_529508
Anti-Mouse SiglecF-PE-CF594 (clone E50-2440) BD Biosciences RRID: AB_2687994
Anti-Mouse CD4-PE-Cy7 (clone RM4-5) BioLegend RRID: AB_312729
Anti-Mouse B220-PerCP (clone RA3-6B2) BioLegend RRID: AB_893354
Anti-Mouse FOXP3-PE (clone 150D/E4) eBioscience RRID: AB_10670338
Anti-Mouse CD36-APC (clone HM36) BioLegend RRID: AB_2072639
Anti-Mouse CD86-BV605 (clone GL-1) BioLegend RRID: AB_11204429
Anti-Mouse CD80-BV (clone 3H5) BD Biosciences RRID: AB_395646
Anti-Mouse TCRVa2-PE (clone B20.1) BioLegend RRID: AB_1134183
Non-phospho (Active) b-Catenin Rabbit mAb (clone D13A1) Cell Signaling Technologies RRID: AB_11127203
PPARg Rabbit mAb (clone C26H12) Cell Signaling Technologies RRID: AB_2166051
Mouse Tubulin mAb (clone GT114) GeneTex RRID: AB_2716636
Mouse GAPDH mAb (clone GT239) GeneTex RRID: AB_11174761
Phospho-Akt Rabbit mAb (Ser473) (clone 193H12) Cell Signaling Technologies RRID: AB_331168
Akt Rabbit mAb Cell Signaling Technologies RRID: AB_329827
Anti-mouse IgG, HRP linked (from sheep) GE Healthcare Life Sciences Cat#NA931V
Anti-rabbit IgG, HRP linked (from donkey) GE Healthcare Life Sciences Cat#NA934V
Anti-Mouse LYVE-1 (clone ALY7) eBioscience RRID: AB_1633414
Anti-Mouse PECAM-1 (clone 390) eBioscience RRID: AB_467201
Chemicals, Peptides, and Recombinant Proteins
TRIzol Reagent Invitrogen Cat#15596026
Collagenase D Roche Cat# 11088882001




SB216763 Abcam Biochemicals Cat# ab120202
Recombinant Wnt10b R&D Systems Cat#2110-WN-010
CFSE Sigma Cat#21888
(Continued on next page)
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Ovalbumin Sigma Cat#S7951
LPS Sigma Cat#L6143
Ovalbumin- Alexa Fluor 555 Invitrogen Cat#034782
BODIPY FL C16 Invitrogen Cat#D3821
Critical Commercial Assays
RNeasy MiniElute cleanup kit QIAGEN Cat#74204
RNeasy Lipid Tissue mini kit QIAGEN Cat#74804
High-Capacity RNA-to-cDNA kit Applied Biosystems Cat#4387406
iTaq Universal SYBR Green Supermix Bio-Rad Cat#1725121
Mouse Adiponectin ELISA kit Merck-Millipore RRID: AB_2651034
Mouse Leptin ELISA kit Merck-Millipore Cat#EZML-82K
Mouse Insulin ELISA kit Merck-Millipore Cat#EZRMI-13K
Mouse Protein Wnt-10b ELISA kit Cusabio Cat# CSB-EL026130MO
Foxp3 / Transcription Factor Staining Buffer Set eBioscience Cat#00-5523-00
LIVE/DEAD Fixable Aqua Dead Cell Stain Kit Invitrogen Cat# L34966
Dead cell removal kit MACS Miltenyi Biotec Cat#130-090-101
Mouse CD11c microbeads (N418) MACS Miltenyi Biotec Cat#130-052-001
Mouse CD4 microbeads (L3T4) MACS Miltenyi Biotec Cat#130-049-201
Mouse IL-10 ELISA kit eBioscience RRID: AB_2574996
Mouse IL-6 ELISA kit eBioscience RRID: AB_2574986
Mouse IL-12p70 ELISA kit eBioscience RRID: AB_2575018
Mouse IL-17A ELISA kit eBioscience RRID: AB_2575100
VECTASHIELD Mounting Medium with DAPI VECTOR laboratories Cat# H-1200
Luminata Forte Western HRP substrate Millipore Cat#WBLUF0500
Deposited Data
Raw data files for RNA sequencing NCBI Gene Expression Omnibus GEO: GSE37448
Experimental Models: Organisms/Strains
Mouse: C57BL/6J Charles River Stock No.027
Mouse: Ppargtm2Rev Jackson Laboratory RRID: IMSR_JAX:004584
Mouse: Ctnnb1tmKem Jackson Laboratory RRID: IMSR_JAX:004152
Mouse: Zbtb46tm1Kmm/J Jackson Laboratory RRID: IMSR_JAX:018534
Mouse: BALB/c Charles River Stock No.028
Mouse: B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-II) Jackson Laboratory RRID: IMSR_JAX:004194
Oligonucleotides
See Table S1 for list of primers N/A N/A
Software and Algorithms
GSEA Broad Institute http://software.broadinstitute.org/
gsea/index.jsp
IMARIS Bitplane http://www.bitplane.com
ImageJ Adiposoft ImageJ, Galarraga et al., 2012 http://imagej.net/Adiposoft
Axiovision version 4.8 Zeiss https://www.zeiss.comCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagentsmay be directed to andwill be fulfilled by the LeadContact, M. Paula Longhi (m.longhi@
qmul.ac.uk).Cell Metabolism 27, 588–601.e1–e4, March 6, 2018 e2
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Male Ppargtm2Rev (Ppargloxp),Ctnnb1tmKem (Ctnnb1loxp), Zbtb46tm1Kmm/J (Zbtb46GFP) and B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-II) mice
were purchased from Jackson Laboratory (US); male C57BL/6 were purchased from Charles river laboratories (UK); male Zbtb46-
Cre+ mice were kindly provided by M. Nussenzweig (The Rockefeller University, NY). Mice were housed in temperature- and humid-
ity-controlled rooms (22C, 55% humidity) with a 12 h light/12 h dark cycle. Mice were fed Chow or Test Diet AIN-76A (Test Diet IPS)
and given water ad libitum; animals were rehoused in clean cages weekly. 15 g of Z-NEST (IPS) was used as nesting material to help
regulate temperature and light levels (Gaskill et al., 2012). For chimeras, 8 – 10 week old C57BL/6 male mice were g-irradiated twice
with 500 rad 3 h apart. Three hours later, mice were reconstituted by intravenous (i.v.) injection with marrow cells (3 3 106) that had
been harvested from the femurs and tibias of conditional Pparg/ (Ppargfl/fl zDC-cre+) and control WT littermates or fetal liver cells
(1x106) from 13 day-old Ctnnb1/ (Ctnnb1fl/fl zDC-cre+) or control embryos. Mice were maintained on acidified water during the
critical 4-week reconstitution period. All animal work was carried out in accordance with UK government Home Office licensing
procedures. Mice fed Western diet were excluded from experiments if they failed to gain more than 20% body weight.
METHOD DETAILS
Real-Time PCR and Expression Profiling
Total RNA was isolated from 106 cells using Trizol (Life Technologies) and with RNeasy MinElute cleanup kits (QIAGEN). RNA from
100 mg visceral adipose tissue was isolated using RNeasy Lipid Tissue Mini Kits (QIAGEN) following the manufacturer’s instructions.
RNA was quantified with Spectrostar omega (BMG Labtech). Reverse transcription to cDNA was performed using High-Capacity
RNA-to-cDNAKits (Applied Biosystems) and stored at - 80C. Primer sequences can be found in Table S1, purchased from Invitrogen,
Paisley,UK.GeneexpressionwasperformedusingSYBRGreenSupermix (Bio-Rad), according to themanufacturer’s instructions, and
analyzed using a CFX connect light cycler (Bio-Rad). Gene-relative expressionwas calculated using theDDCTmethod and normalized
to a reference control (GAPDH)with control sample set as 1. AsDDCT is not normally distributed is the geometricmean is amore appro-
priate representation of thedata than themorecommonly usedarithmeticmean. Tonote, thepropagated error is theproduct ofmultiple
additive errors, thus it will usually be higher than the error implied by taking the standard error of the DDCT values for each replicate.
Expression profiling was performed using publicly available raw data (ImmGen GEO: GSE37448) in R (R Core Team, 2016).
Between-array RMA quantile normalization was performed and unmapped or multi-mapping probes removed prior to differential
expression analysis with limma (Ritchie et al., 2015). Fold change rankings were used in GSEA to identify differentially regulated path-
ways (FDR < 0.25). Processed data are available on ImmGen’s data browsers (http://www.immgen.org/).
Ex Vivo Confocal Microscopy
Zbtb46-GFP mice were injected i.p. with fluorescently conjugated primary antibodies against LYVE-1 (eBioscience) and PECAM-1
(eBioscience) 4 hours prior to surgery. Micewere sacrificed and themesenteric organs including the associated VATwas exteriorized
and fixed in 4% PFA for 10min. Tissue was then mounted on a home-built perplex stage and viewed using a Leica SP8 confocal
microscope as previously described (Arokiasamy et al., 2017). Acquired confocal images were analyzed using the 3D imaging anal-
ysis software IMARIS (bitplane, Switzerland).
Metabolic Assays
Adiponectin and Leptin levels were measured in the serum from fasted lean and obese mice by ELISA (Merck Millipore), as well as by
RT-PCR from visceral adipose tissue as described above. Similarly, fasted insulin levels were detected by ELISA (Merck Millipore).
Wnt10b was detected from visceral adipose tissue homogenates by ELISA (Cusabio). For Glucose (GTT) and Insulin (ITT) tolerance
tests fasted blood glucose levels weremeasured from initial tail bleeds at room temperature using blood glucosemeter and test strips
(FreeStyle Optium Neo, Abbott). Mice were administered with 1.5 mg D- Glucose/ g of body weight (Sigma) or 0.5 U Insulin/ kg of
body weight (Actrapid) via intraperitoneal (i.p.) injection and blood glucose measurements were taken from the tail bleeds at 15,
30, 60, 90, 120, 180 mins after injection at room temperature.
To assess the insulin signaling, mice were injected i.v. with 5 U Insulin/ kg of body weight at room temperature. After 15minutes the
VAT and liver were harvested and tissue levels of phospho-(Ser473) Akt and total AKT were measured by western blot.
Body weight and food intake was recorded weekly. Weight of total visceral adipose tissue harvested was recorded for cell number
calculations and to determine the percentage of bodyweight. Visceral adipose tissuewas fixed in 4%PFA and embedded in paraffin.
Sectioned slides were stained with hematoxylin and eosin by BCI Pathology core services (QMUL). Adipocytes size were calculated
using ImageJ Adiposoft software (Galarraga et al., 2012) by researcher blinded to the tissue genotype. Three fields of view from each
image per mouse were analyzed.
Flow Cytometry Staining
Immune cells from spleen, mesenteric lymph nodes and inguinal lymph nodes were isolated after digestion with Collagenase D
(Roche). For visceral adipose tissue immune cells, tissue was digested with Collagenase II (Sigma) and DNase (Sigma) for 30 min.
Immune cells present in the vascular fraction were obtained after centrifugation and lysed for Red blood cells before staining. Alle3 Cell Metabolism 27, 588–601.e1–e4, March 6, 2018
samples were stained with fixable Aqua Dead cell stain (Invitrogen) to exclude dead cells from analysis. Cells were stained for surface
markers using the following antibodies; CD16/32-FITC, F4/80-PerCP, CD206-BV421, CD11c-BV605, CD103-APC, MHCII-AF700,
CD11b-AF780, MertK-PE, CD45-PE-CF594, CD64-PE-Cy7, CD8-FITC, Ly6G-BV421, NK1.1-BV605, CD3-AF700, SiglecF-PE-
CF594, CD4-PE-Cy7, B220-PerCP, CD36-APC, CD86-BV605, CD80-PE (eBioscience/ BioLegend/ BD Bioscience/ R&D Systems).
Samples were stained at 4C for 30 min and fixed at 4C for 30 min with 1% PFA. For intracellular staining of FOXP3, samples were
incubated in permeabilization/fixation buffer (eBioscience) at 4C for 30 min and washed in permeabilization buffer before staining
with antibody FOXP3-PE (Biolegend) at 4C for 30min in permeabilization buffer. Samples were the analyzed by flow cytometry using
a LSR Fortessa (BD Biosciences) and FlowJo version 10 software.
DC Innate Responses
Dendritic cells were isolated from the spleen and visceral adipose tissue of 3-5 pooled Zbtb46-GFPmice, by first magnetic depletion
of dead cells (MACS Miltenyi Biotec) followed by CD11c+ bead positive selection (MACS Miltenyi Biotec). CD11c+ MHCII+ GFP+
CD103+ CD1 or CD11c+ MHCII+ GFP+ CD11b+ CD2 were purified by cell sorting (FACSAria; BD Biosciences). Cells were plated
at 106 cells/well and stimulated with the TLR4 agonist GLA (IDRI) in the presence or absence of Rosiglitazone 2.5 mM (Sigma) or
SB216763 20 mM (Abcam Biochemicals). In specific experiments cells were additionally stimulated with 100 ng/mL of recombinant
Wnt10b (R&D Sytems). After culturing overnight, supernatant was collected and levels of IL-10, IL-6, IL-12p70 were determined by
murine ELISA (eBioscience).
DC Antigen Presentation
For DC antigen presentation, in vivo, chimera mice were injected intravenously with ovalbumin-specific OT-II cells purified from
spleen and lymph nodes by CD4+ bead positive selection (MACS Miltenyi Biotec) and labeled with CFSE 3 mM (Sigma). The next
day, mice were immunized with 200 mg of Ovalbumin (Sigma) alone or together with 1 mg of LPS (Sigma). Two (after LPS) or three
(after OVA alone) days later, immune cells were isolated from spleen, lymph nodes and visceral adipose tissue and stained, as
described above, for analysis by flow cytometry. The dilution of CFSE in the T cell population was used as an indicator of cell division.
To evaluate OVA uptake by visceral adipose tissue phagocytic cells, 10 mg of OVA-AlexaFluor-555 (Invitrogen) was injected
i.p. One hour later, visceral adipose tissue was harvested and fixed overnight in 4% PFA containing 30% Sucrose (Sigma) and
stain with 0.5 mg/ml of BODIPY as per manufacturer’s instructions (Invitrogen). Tissue was laid onto poly-L-lysine slides with
mounting medium containing DAPI (Invitrogen). Tissue was visualized using a Zeiss Z1 fluorescence microscope (Carl Zeiss,
Cambridge, UK) equipped with an AxioCam MRm Cooled monochrome digital camera and an Apotome 2 Imaging unit. Images
were acquired using a Plan Apochromat 40x or 20x/0.8 NA objective and Axiovision software version 4.8.
To test allostimulatory capacity in vitro, spleen and visceral adipose tissue DCs were isolated, as described above, from lean and
obese Zbtb46-GFP or chimera mice. CD4+ T cells were harvested from the spleen of BALB/c mice by CD4+ bead positive selection
and labeled with CFSE 3 mM. Cells were mixed at a ratio of 1:5 (5 3 104 CD11c+ dendritic cells: 2.5 3 105 CD4+ T cells / well) and
incubated for 3 - 5 days, after which cells were harvested andCFSE dilution was assessed by flow cytometry and cytokine production
in supernatant by ELISA.
Western Blotting
Protein lysates were prepared from tissue or purified cDCs using RIPA buffer. Proteins were separated with SDS-PAGE and trans-
ferred to Immobilon PVDFmembrane (Millipore). Membranes were blocked for 1 h at room temperature in PBST containing 5% (w/v)
milk, incubated overnight at 4C with primary antibodies and subsequently with HRP-conjugated secondary antibody (Amersham
Bioscience). Antibodies against non-phospho (active) b-catenin, PPARg, phospho-(Ser473) Akt and total Akt were purchased
fromCell Signaling Technologies; antibodies against Tubulin, GAPDHwere purchased fromGenetex. Blotted proteins were detected
using Luminata Forte Western HRP substrate (Millipore) and exposed on to Hyperfilm photo film (Amersham).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data reported in the figures represent the average of at least three independent experiments. Statistical significance was determined
by Student’s t test with two-tailed P values of 0.05 or less. For GTT and ITT, statistical significance was evaluated with 2-way ANOVA
followed by Bonferroni post-test. Data were analyzed and charts were generated using Prism 5 (GraphPad Software). Normal
distribution was assessed with Prism 5 using the Kolmogorov-Smirnov and the Shapiro-Wilk normality test. Differences were consid-
ered significant at *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.00005; n.s. non significant.
DATA AND SOFTWARE AVAILABILITY
Data Resources
Rawdata files for the RNA sequencing analysis have been deposited in the NCBIGene ExpressionOmnibus under accession number
GEO: GSE37448.Cell Metabolism 27, 588–601.e1–e4, March 6, 2018 e4
